Literature DB >> 6814919

Cholesterol absorption, elimination and synthesis in coeliac disease.

M Vuoristo, T A Miettinen.   

Abstract

Hypocholesterolaemia and high faecal elimination of cholesterol was explored by measuring the percentage of cholesterol absorbed, faecal steroids, serum cholesterol and dietary cholesterol in patients with coeliac disease before and after a gluten free diet. From these data, the total and endogenous flux of cholesterol into the gut and the amount of cholesterol absorbed could be calculated. The mean faecal bile acid excretion was normal, but faecal endogenous steroids and thus faecal total steroids, and the cholesterol synthesis, were increased in the patients. The percentage of cholesterol absorbed was quite low (15.1 +/- 2.1 (SEM) v. 34.1 +/- 2.5 in the controls), and it was attributable to a mucosal damage in the upper small intestine, suggesting that this played a primary role in the high faecal sterol loss. However, the influx of endogenous cholesterol into the gut had increased, so that in absolute terms the absorption of cholesterol was low only inconsistently. The gluten-free diet caused the opposite changes in the absorption percentage and influx of cholesterol into the gut, while the amount of cholesterol absorbed was only insignificantly increased. Serum cholesterol was significantly correlated with the cholesterol absorbed (r = 0.36; P less than 0.01), faecal endogenous steroids (r = -0.30; P less than 0.05), and cholesterol synthesis (r = -0.29; P less than 0.05). Furthermore, the rise in serum cholesterol during the gluten-free diet correlated negatively with the changes in cholesterol (r = -0.55; P less than 0.05) and bile acid (r = -0.77; P less than 0.01) synthesis. These associations and the lack of correlations between the amounts of cholesterol absorbed and synthesized suggest that the serum cholesterol level and regulation of cholesterol synthesis are interrelated in coeliac disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814919     DOI: 10.1111/j.1365-2362.1982.tb02234.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

Review 1.  Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between coeliac disease and cholesterol gallstone disease.

Authors:  Helen H Wang; Min Liu; Xiaodan Li; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2017-03-08       Impact factor: 4.686

2.  Raised plasma cholesterol precursors in patients with gut resections.

Authors:  M A Färkkilä; R S Tilvis; T A Miettinen
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

3.  Serum cholesterol precursor sterols in coeliac disease: effects of gluten free diet and cholestyramine.

Authors:  M Vuoristo; T A Miettinen
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

4.  Enhanced synthesis of cholesterol and its precursors in jejunal mucosa in coeliac disease.

Authors:  M Vuoristo; T A Miettinen
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

5.  Lack of endogenous cholecystokinin promotes cholelithogenesis in mice.

Authors:  H H Wang; M Liu; P Portincasa; P Tso; D Q-H Wang
Journal:  Neurogastroenterol Motil       Date:  2015-11-25       Impact factor: 3.598

6.  Markers of inflammation and cardiovascular disease in recently diagnosed celiac disease patients.

Authors:  Walter F Tetzlaff; Tomás Meroño; Martin Menafra; Maximiliano Martin; Eliana Botta; Maria D Matoso; Patricia Sorroche; Juan A De Paula; Laura E Boero; Fernando Brites
Journal:  World J Cardiol       Date:  2017-05-26

7.  Screening of Altered Metabolites and Metabolic Pathways in Celiac Disease Using NMR Spectroscopy.

Authors:  Ensieh Khalkhal; Mostafa Rezaei-Tavirani; Fariba Fathi; B Fatemeh Nobakht M Gh; Amir Taherkhani; Mohammad Rostami-Nejad; Nastaran Asri; Mohammad Hossain Haidari
Journal:  Biomed Res Int       Date:  2021-11-15       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.